Advancing Treatments for Rare Eye Diseases in Europe
Restore Vision is a project funded by the European Commission aiming to develop and test new treatments for 7 rare eye diseases (REDs). The consortium joins 10 European key players on rare eye diseases and is led by University of Galway.
About Restore Vision
+30 million
people suffer from blindness and visual impairment
About Restore Vision
Over the the next 4 years (2023-2027) the Restore Vision consortium will explore new treatments for 7 REDs by repurposing existing generic drugs, developing new therapeutic compounds, and conducting pioneering clinical trials to ensure their safety and effectiveness.
Learn more about our work
Project in numbers
0
Years (2023-2027)
0
Partners
0
mil EUR in funding
0
EU Countries
0
Work packages
Watch our video:
News
Read Restore Vision’s latest news.
28 February 2026
Surgeries, complications and emergency hospital visits – life with aniridia
“It often feels as if I have lived at the eye hospital more than at home, due to surgeries, complications, and emergency visits.” This is the story from Marie Olsson, 44 years old from a small town called Katrineholm in Sweden, who was born with an eye condition called aniridia.
Read more
25 November 2025
Restore Vision’s latest progress
Where do we stand now in our journey of advancing treatments for rare eye diseases in Europe?
Read more
09 October 2025
A journey of resilience and adaptability – life with aniridia
Today it’s World Sight Day – a global awareness day dedicated to the importance of eye health, vision care, and the prevention of blindness and visual impairment. Behind this message are real-life stories of people dealing with visual impairment. Today, we share the story of Irma, 38 years old, originally from Lithuania, and mother of two children – a daughter of 12 and son of 8 years old. Her son was born with a rare genetic eye condition, called aniridia.
Read more
22 July 2025
New study: Enhancing Immune Modulation with “trained” MSC-EVs
In this study, the Restore Vision team at Galway explored whether EVs from MSCs that were specially “trained” using two immune-related proteins – TGF-β1 and IFN-γ – could more effectively regulate the immune system than EVs from untrained cells.
Read more
08 May 2025
Join our Patients Working Group!
Are you living with a rare eye disease? Or are you a caretaker of someone who is? Join the Patients Working Group of the international research project Restore Vision! [Available in EN, IT, ES, FR, SE, DE]
Read more
Interested in Restore vision?
Stay informed about our efforts to combat rare eye diseases and bring new hope to those affected by visual impairment by subscribing to our newsletter for updates on our latest treatments and research.